| 注册
首页|期刊导航|临床肝胆病杂志|基于目标导向的原发性肝癌中医药防治疗效评价体系的构建

基于目标导向的原发性肝癌中医药防治疗效评价体系的构建

张宁 陆荫英

临床肝胆病杂志2026,Vol.42Issue(5):1009-1014,6.
临床肝胆病杂志2026,Vol.42Issue(5):1009-1014,6.DOI:10.12449/JCH260504

基于目标导向的原发性肝癌中医药防治疗效评价体系的构建

Construction of a goal-oriented efficacy evaluation system for traditional Chinese medicine in the prevention and treatment of primary liver cancer

张宁 1陆荫英2

作者信息

  • 1. 中国人民解放军总医院肝病医学部,北京 100039||南方医科大学中医药学院,广州 510515
  • 2. 中国人民解放军总医院肝病医学部,北京 100039
  • 折叠

摘要

Abstract

Traditional Chinese medicine(TCM)plays an important role in the full-cycle management of primary liver cancer;however,the current evidence-based evaluation system with the main assessment index of objective tumor remission is mainly centered on randomized controlled trials and systematic reviews/meta-analyses and cannot fully reflect the characteristics and advantages of TCM.Based on the current status of TCM efficacy evaluation in the prevention and treatment of liver cancer,this article proposes the construction of a multi-dimensional evaluation system that is oriented by stage-specific treatment goals and integrates outcome indicators with process indicators.Outcome indicators include modern medical endpoints such as overall survival and recurrence-free survival,and process indicators include short-term outcomes such as the improvement in TCM syndrome,patient-reported outcomes,the remission rate of adverse events,and the discontinuation rate of the core regimen.It is emphasized that the development of standardized TCM regimens should follow the order of theoretical connotation,accumulation of proven cases,observational evaluation,and interventional evaluation.Furthermore,it is recommended to incorporate artificial intelligence approaches into this evaluation system,so as to promote the intelligent and precise assessment of TCM efficacy.

关键词

肝肿瘤/中医药疗法/实体肿瘤疗效评价标准

Key words

Liver Neoplasms/Traditional Chinese Medicine Therapy/Response Evaluation Criteria in Solid Tumors

引用本文复制引用

张宁,陆荫英..基于目标导向的原发性肝癌中医药防治疗效评价体系的构建[J].临床肝胆病杂志,2026,42(5):1009-1014,6.

基金项目

国家科技重大专项(2024ZD0526200) National Science and Technology Major Project(2024ZD0526200) (2024ZD0526200)

临床肝胆病杂志

1001-5256

访问量0
|
下载量0
段落导航相关论文